Stevens-Johnson syndrome natural history, complications and prognosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
SJS proper (with less than 10% of body surface area involved) has the [[mortality rate]] of around 5%. The risk for death can be estimated using the '''SCORTEN scale''', which takes a number of prognostic indicators into account. | SJS proper (with less than 10% of body surface area involved) has the [[mortality rate]] of around 5%. The risk for death can be estimated using the '''SCORTEN scale''', which takes a number of prognostic indicators into account.Other outcomes include organ damage and blindness. | ||
Other outcomes include organ damage and blindness. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Medical emergencies]] | [[Category:Medical emergencies]] |
Revision as of 17:42, 11 February 2013
Stevens-Johnson syndrome Microchapters |
Differentiating Stevens-Johnson Syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Stevens-Johnson syndrome natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Stevens-Johnson syndrome natural history, complications and prognosis |
FDA on Stevens-Johnson syndrome natural history, complications and prognosis |
CDC on Stevens-Johnson syndrome natural history, complications and prognosis |
Stevens-Johnson syndrome natural history, complications and prognosis in the news |
Blogs on Stevens-Johnson syndrome natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
SJS proper (with less than 10% of body surface area involved) has the mortality rate of around 5%. The risk for death can be estimated using the SCORTEN scale, which takes a number of prognostic indicators into account.Other outcomes include organ damage and blindness.